|
|
||||||||
Brief Report |
From Outcomes Research and Management, Merck & Co., Inc., West Point, PA (FAR, TWW, LEM); Brainerd Medical Center, Brainerd, MN (WFS); Atlanta Pulmonary Group, Atlanta, GA (DW); and Temple University Hospital, Philadelphia, PA (NM)
Correspondence: Corresponding author: Thomas W. Weiss, DrPH, Merck & Co., Inc., P.O. Box 4 (WP39-170), West Point, PA 19486 (e-mail: Thomas_Weiss{at}merck.com)
Purpose: To estimate the prevalence of atopy (ie, allergen sensitization) in a sample of adult asthma outpatients.
Methods: Population consisted of a total of 218 patients, 18 to 55 years of age, who were currently receiving care for asthma; and 13 physicians, whose specialties were Family Practice, Allergy, or Pulmonology and who were providing care to at least 10 to 15 asthma patients weekly. Patients provided a blood sample for quantification of total and allergen-specific IgE. Outcomes were the proportion of patients with atopy and the proportions of patients with elevated serum IgE specific to each of 8 specific common allergens.
Results: The patients mean age was 42 years, and 74% were women; 68% of patients met the study definition of atopy. Total serum IgE
114 kU/L was observed in 48% of patients, and 59% had elevated levels of IgE specific to one or more of 8 common allergens.
Conclusions: The majority of adult asthma outpatients had evidence of atopy and most were sensitive to a specific identifiable allergen. Awareness of the high prevalence of atopy among asthma patients might improve patient management.
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |